Department of Pharmacy, Saitama Cancer Center, Saitama, Japan.
Department of Palliative Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.
J Bone Miner Metab. 2023 May;41(3):327-336. doi: 10.1007/s00774-022-01382-y. Epub 2022 Nov 23.
Bone metastases frequently occur in patients with cancer. Skeletal-related events (SREs), including pain, impaired mobility, hypercalcemia, pathological fracture, spinal cord and nerve root compression, and bone marrow infiltration, can decrease the quality of life of the patients and increase the risk of morbidity. The mechanism of pain due to bone metastasis is complicated and involves various interactions among tumor cells, bone cells, activated inflammatory cells, and bone-innervating neurons. Cancer pain due to bone metastasis can be crippling and a chronic state that causes sarcopenia. For pain management, it is important to diagnose whether the pain is based on background pain or breakthrough pain due to bone metastasis. In addition, the management goal of cancer pain due to bone metastasis is not only to achieve pain relief but also to prevent pain progression and SREs. Pain mechanisms should be applied to achieve optimal management. This review aims to discuss the mechanisms of cancer pain due to bone metastasis and review the recommended drug therapies.
癌症患者常发生骨转移。骨骼相关事件(SREs),包括疼痛、活动能力受损、高钙血症、病理性骨折、脊髓和神经根压迫以及骨髓浸润,可降低患者的生活质量并增加发病风险。骨转移所致疼痛的机制较为复杂,涉及肿瘤细胞、骨细胞、激活的炎性细胞和骨内神经元之间的各种相互作用。骨转移所致癌症疼痛可能致残,并呈慢性状态导致肌肉减少症。对于疼痛管理,重要的是要诊断疼痛是基于背景疼痛还是由于骨转移引起的爆发性疼痛。此外,骨转移所致癌症疼痛的管理目标不仅是缓解疼痛,还要预防疼痛进展和 SREs。应采用疼痛机制来实现最佳管理。本综述旨在讨论骨转移所致癌症疼痛的机制,并回顾推荐的药物治疗方法。